Highlights: -ASTRAL trial results show no benefit for renal artery stenting -Cutting balloon no better than angioplasty -Setback for drug elution in the periphery as STRIDES follows SIROCCO -Profile: Roy Greenberg
[pdfviewer width=”100%” height=”940px” beta=”true”]http://vascularnews.com/wp-content/uploads/sites/7/2016/02/44-Vascular-Europe_low-res.pdf[/pdfviewer]
